Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

People who live with narcolepsy — about one out of ... to patent a Risk Evaluation and Mitigation Strategy, there are currently 62 medications that require a REMS. Xyrem is one of three that ...

Narcolepsy is a sleep-wake disorder with an onset commonly seen in individuals aged 10–30 years. Due to various reasons, the diagnosis of narcolepsy often experiences a delay of at least ten years.

Narcolepsy is generally treated with medication. Some medications are effective for sleepiness, some are effective for cataplexy, some are effective for other associated symptoms, and some are ...

There are two types of narcolepsy—type 1 and type 2. Type 1 may include the presence of the symptom ... The diagnosis should be made by a sleep specialist who is able to apply the proper testing and ...

Central nervous system (CNS) specialist Neuraxpharm Group has acquired Provigil (modafinil) and Nuvigil (armodafinil), both of which are indicated for the treatment of excessive daytime sleepiness ...

Methylphenidate Medications There are two types of stimulants: amphetamines ... This medication is Food and Drug Administration (FDA)–approved to treat ADHD and narcolepsy (a medical condition ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...

Assuming they all win approval, the clutch of potential new drugs could ... Weber described narcolepsy type 1 as a rare disease that’s “not so rare,” noting that there are about 100,000 ...

Selecting the most effective medication for an adult with attention deficit hyperactivity disorder (ADHD) can involve trial and error. The best medication for adult ...

Alkermes wants to augment its pipeline with M&A or licensing deals in serious mental illnesses and substance abuse. “I think anyone who's developing a drug in these spaces, they are probably better ...

E-2086 is under clinical development by Eisai and currently in Phase I for Narcolepsy. According to GlobalData, Phase I drugs for Narcolepsy have an 80% phase transition success rate (PTSR) indication ...